Rafarma Pharmaceuticals, Inc. (RAFA) has a market capitalization of $5.7M and trades at $0.07. The 52-week range is 0.004-0.15.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 21.7, Earnings Per Share (EPS) of $0.00, annual revenue of $9.08M.
The stock has a beta of 0.54, operates in the Healthcare sector.
